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1013-7025/Copyright ª 2014, Hong Kong PhAbstract Background: Exercise training (ET) has been recommended as an adjunctive ther-
apy in chronic heart failure but the role of ET in people with biventricular heart failure
(BVF) has not been explored in Nigeria.
Objective: This study aimed to investigate the role of ET on functional walking capacity and
activity level of Nigerians with BVF.
Methods: Sixty-six patients with chronic BVF in New York Heart Association Class II and III
(mean age 54.0  1.6 years) recruited from a Nigerian tertiary hospital participated in the
study. They were randomized into either the exercise group or control group. These patients
were on their prescribed medications and underwent education/counselling sessions. In addi-
tion, patients in the exercise group performed aerobic and resistance training thrice weekly
for 12 weeks. Functional walking capacity was assessed using the 6-minute walk test, oxygen
consumption was estimated using the Duke Activity Status Index questionnaire while the Vet-
erans’ Specific Activity questionnaire was used to assess the activity level.
Results: The exercise group had significant improvements in all components of functional
walking capacity and activity level. No significant improvement was observed in controls
(p < 0.05).
Conclusion: Supervised and structured ET is safe and beneficial for patients with BVF.
Copyright ª 2014, Hong Kong Physiotherapy Association Ltd. Published by Elsevier (Singapore)
Pte Ltd. All rights reserved.of Physiotherapy, Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria.
com (O.A. Ajiboye).
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43IntroductionHeart failure (HF) is characterized by the inability of the
heart muscle to pump an adequate volume of blood to meet
tissue energy demand that results in symptoms of fatigue or
dyspnoea initially on exertion and then later on progressing
to dyspnoea at rest [1,2]. It is a common and disabling
syndrome that is a final pathway for a number of cardiac
conditions [3]. HF is the most prevalent cardiovascular
disease and the leading cause of sudden cardiac death in
Nigeria [4]. Although the management of HF once focused
exclusively on pump performance, HF is now considered a
disorder whereby the peripheral effects of the disease are
so debilitating that they warrant a treatment strategy that
focuses on skeletal muscle improvement and improved
exercise tolerance [3,5].
Despite major advances in pharmacological treatment of
HF, the number of people afflictedwithHF is rising yearly and
many patients suffer from dyspnoea, fatigue, diminished
exercise capacity, and poor quality of life [6]. In the past,
patients with HF were advised to avoid physical exertion in
the hope that bed rest might minimize symptoms and in the
belief that physical activitymight accelerate the progression
of left ventricular dysfunction [7]. It is now known that a
reduction in physical activity either produced by the symp-
toms of HF or prescribed by physicians treating HF leads to a
state of physical deconditioning that contributes to these
symptoms including exercise intolerance [8]. All these
symptoms may lead to a significant reduction in physical and
mental health, which results in amarkedly decreased quality
of life. However, in addition to pharmacotherapy, exercise
training has been reported to have a place in itsmanagement
especially in patients with left ventricular HF [9,10]. The
majority of previous studies focused on HF of ischaemic
origin and among Caucasians. However, there is need to
understand the response to exercise training in other pop-
ulations with systolic biventricular HF secondary to either
hypertension or cardiomyopathy.
Despite recommendation of exercise training in most
guidelines as a useful intervention for patients with stable
chronic HF, acceptance of exercise training by the medical
community as an adjunct in patient management has been
less enthusiastic [3]. Many physicians remain concerned
about implementation of exercise programme in this high-
risk group, in terms of methodology and safety [11]. Stan-
dard exercise training protocols usually involve a combi-
nation of aerobic and resistance training. Beckers et al [12]
demonstrated in HF patients that combined exercise
training had a more pronounced effect on submaximal ex-
ercise capacity, muscle strength, and quality of life than
pure endurance training, without unfavourable effects on
left ventricular remodelling and outcome parameters [12].
Robust data on improvement in outcomes of exercise
training in patients with chronic HF of ischaemic aetiology
due to left ventricular dysfunction exist among Caucasians.
There seems to be a dearth of literature for reference in
Nigeria where HF is mainly nonischaemic in aetiology and
the sufferers present late for medical care with biven-
tricular HF. Thus, supervised exercise training has not been
part of HF management in Nigeria. To address these gaps in
knowledge, the present study investigated the role ofexercise training on exercise walking capacity and activity
level of Nigerians with stable biventricular HF.
Methods
Study design
A randomized controlled trial design was used in this study.
There were two treatment arms: exercise group and control
group. Outcome measurements were performed at baseline
and immediately after the 12-week intervention period.
Patients
Patients were recruited from a population of chronic HF
patients receiving treatment at the cardiology clinic of
Lagos University Teaching Hospital, Lagos, Nigeria. They
were in Class II and III of the New York Heart Association
(NYHA) classification. The study was carried out in the
medical gymnasium of the Physiotherapy Department,
Lagos University Teaching Hospital. Sample size was
calculated using the equation postulated by Eng [13]. The
minimum number of patients expected to participate in the
study was 46, with 23 in each group.
The patients involved in this study were Nigerians diag-
nosed with biventricular chronic HF secondary to hyper-
tension or of dilated cardiomyopathy. The patients were
oriented to person, place, and time, in Class II and III of
New York Heart Association (NYHA) classification, on their
standard pharmacologic therapy for HF (diuretics, ACE in-
hibitors, b blockers, and digoxin). They had no change in
medical therapy for at least 30 days with resting ejection
fraction  40% as measured by echocardiography medical
diagnosis of HF either hypertensive or idiopathic in origin.
Individuals with the following conditions were excluded
from participating: chronic HF of ischaemic origin, valvular
diseases, and rheumatic diseases, clinical evidence of
decompensated HF, atrial fibrillation, acute HF within the
previous 3 months, unstable angina pectoris, end-stage
renal disease, or orthopaedic impediments to exercise and
patients participating in a formal exercise programme
within 30 days prior to this study.
Ethical considerations
The protocol for this study was approved by the Health
Research and Ethics Committee of the Lagos University
Teaching Hospital, Idi-Araba, Lagos, Nigeria before the
commencement of the study. Written consent was also
obtained from patients prior to enrolment into the study.
All experiments were done in accordance with the Decla-
ration of Helsinki.
Randomization
The patients were randomized into the exercise group or
control group. A randomization list was produced by a
computer generated random-number sequence in blocks of
10 to ensure consistent patient distribution in both groups.
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patients were told to pick as they reported for the study.
Education and counselling sessions
All patients recruited for this study participated in educa-
tional sessions. These were given prior to commencement,
at the end of the 6th week and at the end of the 12th week
of the study. The sessions included general health talk on
prevention of complications, lifestyle modification, and
healthy living.
Control group
Patients in the control group received their medical care
for HF, including standard pharmacological treatment at
the HF clinic. They were encouraged to continue their usual
activity levels and instructed not to initiate any new ex-
ercise training during the 12-week study period.
Exercise group
Patients in the exercise training group received the same
medical care from the cardiology clinic plus aerobic and
resistance training. The exercise protocol was structured
according to the guidelines for patients in functional Clas-
ses II and III [14]. The exercise training intervention was
given 3 d/wk over 12 weeks (36 sessions). Patients were
monitored throughout the training sessions and supervised
by the researcher and a research assistant who had been
trained in the study protocol. Each exercise session lasted
60 minutes (10-minute warm-up phase, 20-minute aerobic
phase, 20 minutes of strength/resistance training, and 10-
minute cool-down phase).
All patients in the exercise group performed 10 minutes
of warm-up exercises in the form of mild aerobic exercises,
stretching/flexibility exercises. This involved a range of
motion exercises in all the major joints of the upper, lower
limbs, and trunk. The warm-up exercise was done caudo-
cephally. Each joint was moved at 10 repetitions.
Aerobic exercise training was conducted using an elec-
tronic bicycle ergometer (Body Coach, China). The exercises
were administered according to individual tolerance. During
the 20-minute aerobic phase, patients were monitored with
a Polar heart rate monitor (model Pulse Sonic China) and the
exercise was maintained at 60e70% peak heart rate and the
blood pressure checked at interval of 2e5 minutes using a
sphygmomanometer digital blood pressure monitor (model
HEM- 712 CLCN2, Omron Healthcare Inc., Bannockburn, IL,
USA). Intensity of the exercise was maintained at Level 3e4
of perceived exertion on the modified Borg scale of
perceived exertion. The loading on the ergometer was also
progressed by 5 W individually depending on their responses
to treatment at the end of eachmonth. Exercise trainingwas
performed three times weekly for 3 months between 8.00 AM
and 12.00 noon. The modified Borg [15] scale of perceived
exertion was used to assess the intensity.
The muscle strength of the upper and lower limbs was
assessed using dumb bells, hand dynamometer, and sand
bags of known weights. Patients in the exercise group
performed three sets of 50% of one repetition maximum(1RM) for 10 repetitions of four major muscle groups in both
the upper and lower limbs (elbow flexioneextension and
knee extensioneflexion exercises) per set from the 1st week
to the 6th week, 60% of 1RM for 10 repetitions per set from
the 7th week to the 12th week. The 20 minutes of strength/
resistance training included patients performing light
upper-body exercises (hand grip, flexion, extension,
adduction, and abduction at the shoulder joints at 10 rep-
etitions of 20e25% of 1RM) and lower-body exercises (hip
extension, flexion, adduction, abduction). Exercises such as
reciprocal pulley and stair climbing were also included in
the 20-minute strength/resistance training. Patients were
monitored using polar heart rate monitor and the blood
pressure was checked at intervals. The modified Borg scale
of perceived exertion was used to monitor the intensity.
These exercises were done three times weekly for 12
weeks. Patients were asked to rest for at least 10 minutes
after the training. One minute of recovery period was
observed by the patients following performance of a set of
resistance exercise by each muscle group.
All patients in the exercise group performed 10 minutes
of cool-down exercises after the aerobic training. These
involved range-of-motion exercises in all of the major joints
of the upper and lower limbs and the trunk before and after
commencing resistance training.
Outcome measurements
At baseline, sociodemographic data (e.g., sex, age, race,
marital status) and health history data were obtained
through interview and patients’ hospital files. Height and
weight were measured using a stadiometer scale (Health
Scale ZT-120; Seradon (Model ZT 120), China). Measure-
ment of the following outcome variables were performed at
baseline and 12th week of exercise training.
Six-minute walk test
The 6-minute walk test (6MWT) was used as a measure of
functional status and exercise capacity. The 6MWT was
carried out using a 30-m straight walk course marked out on
the flat surface of the medical gymnasium with chair placed
at both ends of the course. The research assistant who
conducted the 6MWT was blinded to the group allocation.
The participant was instructed to stand at the zero mark of
the walk course, and then walk at their own pace, in order
to cover as much ground as possible in a period of 6 mi-
nutes. They were allowed to stop and rest during the test in
case of fatigue, but were instructed to resume walking as
soon as they were able to do so. A pulse oximeter was used
to monitor the oxygen saturation level (Model Lifeline
Medical Devices, Haryana, India), The total walking dis-
tance covered during this period was measured and recor-
ded in metres [16e18].
The estimated peak oxygen consumption was calculated
from formulae derived from Duke Activity Status index
(DASI) [19].
VO2peak Z (0.43  DASI) þ 9.6 mL/kg/min [1]
Metabolic equivalent Z VO2peak/3.5 mL/kg/min [2]
45Veteran’s Specific Activity Questionnaire was also used
to assess the activity level of these patients [20].
Cardiovascular-respiratory function
Resting arterial blood pressure (systolic and diastolic) was
measured with Omron automatic blood pressure monitor
(model HEM- 712 CLCN2; Omron Healthcare Inc.). This in-
strument was validated using an Accoson Mercury sphyg-
momanometer. Regular checks for consistency were done
routinely every week. Patients were required to be seated
for at least 20 minutes before the measurements were
taken following standardized methods [16,21]. The average
of two systolic and two diastolic blood pressure meaa-
surements were recorded respectively. The unit of mea-
surement was mmHg. Resting heart rate was measured
using Omron automatic blood pressure monitor while polar
heart rate monitor was used to monitor the heart rate
(beats/min) during the exercise.
A pulse oximeter (Model Lifeline Medical Devices, Har-
yana, India) was used to measure oxygen saturation level
(%) of the patients. Resting respiratory rate (breaths/min)
was determined by observing the chest excursions. Borg’s
scale of perceived exertion was used to assess rate of
perceived exertion as a measure of level of fatigue and
dyspnoea.199 met inclusion cr
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Figure 1. Study flow chart. A total oData analysis
SPSS version 17 (SPSS Inc., Chicago IL, USA) was used to
analyse the data. Descriptive statistics (mean, standard
error of the mean) were computed for all study variables as
appropriate. Independent t test was used to analyse
between-group differences while paired t test was used to
analyse within-group differences over time in all the
parametric variables in this study. Wilcoxon signed rank
test was used to analyse nonparametric data of New York
Heart Association class within the groups. The level of sig-
nificance was set at p < 0.05.Results
A total of 199 individuals (107 men, 92 women) fulfilled all
eligibility criteria, of whom only 80 gave their consent; 69
reported for the study and were randomized into the con-
trol group and exercise group with intention to treat
(Fig. 1). Three patients were denied participation because
they showed some signs of decompensation during baseline
assessment. The total number of patients that completed
the study was 51 (28 in the exercise group, 23 in the control
group). Twenty-five of these individuals were in NYHA Class
II and 26 were in Class III.iteria
t
119 declined
11 did not turn up
Exercise group (n = 35) had 
baseline assessment
Signs of 
decompensation 
(n = 2)
28 completed follow-up 
assessment
Received allocated 
treatment (n = 33)
Could not meet 
80% attendance 
(n = 5)
f 51 patients completed the study.
Table 1 Physical characteristics of patients in both groups as a whole, and in the exercise and control groups individually.
Physical characteristics Both groups
Mean  SEM
(N Z 51)
Control group
Mean  SEM
(n Z 23)
Exercise group
Mean  SEM
(n Z 28)
t p
Age (y) 54.0  1.6 51.5  2.6 56.1  2.0 1.442 0.156
Height (m) 1.65  0.01 1.65  0.02 1.65  0.02 0.097 0.923
Weight (kg) 77.0  2.0 75.1  3.4 78.6  2.4 0.867 0.390
Body mass index (kg/m2) 28.6  0.7 27.7  1.3 29.1  0.9 0.969 0.338
Level of significance: p < 0.05.
SEM Z standard error of the mean.
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had systolic biventricular HF secondary to hypertension and
19 (37.3%) had biventricular HF secondary to dilated car-
diomyopathy. None of the patients that participated
showed adverse cardiac response to the training program
and no severe long-term adverse events occurred.
Physical characteristics of the patients
Table 1 shows the physical characteristics of patients in the
two groups. There was no significant difference in the age,
height, weight, body mass index, distance walked in 6 mi-
nutes (6MWD), or classification according to NYHA standard
between the two groups (p > 0.05).
Table 2 shows comparisons of functional walking capacity.
There was a significant reduction in the functional capacity
as measured by peak oxygen consumption as estimated by
DASI (pZ 0.002) in the control group. The change in 6MWD,
however, was not statistically significant (pZ 0.168). Among
the controls, 13 patients were in NYHA Class II and 10 in Class
III at baseline. After the 12-week study period, 15 patients
were in Class II with 8 patients were in Class III. This change
was not statistically significant (p = 0.157).
In the exercise group, there were significant improve-
ments in the 6MWD (p < 0.001) and peak oxygen con-
sumption as estimated by DASI (p < 0.001). Twelve patients
were in Class II and 16 patients were in Class III prior to the
exercise intervention. After the 12 weeks of exerciseTable 2 Within-group analysis of outcome variables.
Variables Control group t value/z
value
p
Pretest
Mean  SEM (a)
Post-test
Mean  SEM (b)
6MWD (m) 404.0  6.9 399.0  12.1 1.482 0.
PVO2-DASI
(mL/kg/min)
12.7  0.2 12.2  0.2 3.495 0.
PVO2-VSAQ
(mL/kg/min)
14.9  0.5 14.1  0.5 1.344 0.
NYHA class 13/2; 10/3 15/2; 8/3 1.414 0.
*p  0.05; **p  0.001.
6MWD Z distance walked in 6 minutes; NYHA class Z New York Hea
mated from the Duke Activity Status Index questionnaire; PVO2-VSAQZ
Activity Questionnaire; SEM Z standard error of the mean.training, 14 patients were in NYHA Class I, 13 patients were
in Class II, and only 3 patients were in Class III. This change
was statistically significant.
A comparison between the groups showed no significant
difference at baseline in all the variables of functional
capacity but significant differences were observed after the
intervention period (p < 0.05). Table 3 shows the mean
changes in 6MWD, estimated peak oxygen consumption and
activity level in the control and exercise groups after 12
weeks of intervention. There was a significant difference in
mean changes in the 6MWD, estimated oxygen consump-
tion, and activity level (p < 0.001) between the two groups.
Fig. 2 shows the comparison of changes in selected
cardiorespiratory variables between patients in the control
and exercise groups after 12 weeks of the study. There were
significant difference in mean changes in the resting heart
rate (p Z 0.030), rate of perceived exertion, and resting
respiratory rate (pZ 0.004) while a significant difference in
change was observed in oxygen saturation (p < 0.001) be-
tween the two groups, in favour of the exercise group. No
significant change was observed in the resting diastolic
blood pressure (pZ 0.105) or resting systolic blood pressure
(pZ 0.085) after the 12 weeks of intervention.
Discussion
This study investigated the effects of aerobic and resis-
tance exercise training on functional walking capacity andExercise group t value/z
value
p
Pretest
Mean  SEM (c)
Post-test
Mean  SEM
(d)
168 414.1  8.8 448.8  6.6 5.871 < 0.001**
002* 12.8  0.2 15.0  0.2 13.426 < 0.001**
209 13.8  0.4 21.9  0.5 16.156 < 0.001**
157 12/2; 16/3 14/1; 13/2; 2/3 4.817 <0.001**
rt Association class; PVO2-DASI Z peak oxygen consumption esti-
peak oxygen consumption estimated from the Veteran’s Specific
Table 3 Between-group comparison of change scores of functional walking capacity, estimated peak oxygen consumption and
activity level after 12 weeks of exercise training.
Variables Control group Exercise group t p
D 6MWD (m) 5.5  3.7 34.8  5.9 4.278 < 0.001
D in PVO2 DASI (mL/kg/min) 0.5  0.1 2.2  0.2 12.252 < 0.001
D VSAQ (metabolic equivalents) 0.3  0.2 2.2  0.2 9.290 < 0.001
D 6MWDZ change in 6-minute walk distance; D PVO2 DASIZ change in peak oxygen consumption as estimated from the Duke Activity
Status Index questionnaire; D VSAQZ change in activity level as measured by the Veteran’s Specific Activity Questionnaire.
47activity level of Nigerians with chronic biventricular HF. In
recent years, it has become evident that peripheral skel-
etal abnormalities are responsible for exercise intolerance
and limitation seen in many patients with chronic HF [3,5].
The results of this study demonstrated beneficial effects of
aerobic and resistance training on functional walking ca-
pacity and activity level of Nigerians with stable biven-
tricular HF.
Methodological considerations
Some of the limitations encountered were that some of the
patients with chronic HF were unwilling to participate in
the study due to the fear of worsening conditions with ex-
ercise. Many of these patients came from other parts of the
country to attend the cardiology clinic in Lagos and so were
unable to stay in Lagos for thrice weekly appointments for a
period of 12 weeks. These factors affected the number of
patients who volunteered to participate for the study.
Larson et al [22] in their study compared maximal, sub-
maximal, and endurance exercise protocols in assessing the
effects of exercise training in congestive HF and concluded
that although maximal cycle tests are commonly used in
clinical work, submaximal and endurance exercise tests
might be preferable for evaluating new treatment regimens
in this population as they are easy to perform, reproduc-
ible, and reflect daily tasks better than the maximal cycle
test in this population. Some of the sophisticated equip-
ment that could be used as a “gold standard” forC
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Figure 2. Between-group comparisons of change scores in cardio
(mmHg); RHRZ resting heart rate (beats/min); RPEZ rate of perc
rate (breaths/min); RSBP Z resting systolic blood pressure (mmHgcardiopulmonary exercise testing was not readily accessible
in Nigeria, thus the need to use readily available and
inexpensive outcome measures for the study, to make it
reproducible in other parts of the country. Another limita-
tion observed in this study is the use of DASI to estimate
oxygen consumption, which is a measure of functional ca-
pacity of these patients. This may underestimate the oxy-
gen consumption, and because this was the first study of its
kind in Nigeria, it is advisable that further study should
incorporate the use of cardiopulmonary exercise testing to
assess oxygen consumption.
The 6MWT, one of the outcome measures used in this
study, is a widely used measure of functional exercise ca-
pacity in individuals with cardiovascular, cardiopulmonary,
and other chronic diseases. It has advantages over
laboratory-based tests of exercise tolerance as it more
closely resembles the ability to perform activities of daily
living and does not require sophisticated equipment [23].
The 6MWT evaluates the global and integrated responses of
all the systems involved during exercise, including the
pulmonary and cardiovascular systems, systemic circula-
tion, peripheral circulation, blood, neuromuscular units,
and muscle metabolism [23,24].
The 6MWD shows moderate to good correlation with the
peak oxygen uptake measured during an incremental cycle
ergometry test in patients with moderate to severe chronic
obstructive pulmonary disease [25,26] and congestive HF
[27,28]. It is frequently used as an outcome measure in
cardiopulmonary and cardiovascular rehabilitation and asrespiratory variables. RDBP Z resting diastolic blood pressure
eived exertion (modified Borg scale); RRRZ resting respiratory
); RSPO2 Z resting blood oxygen saturation (%).
48 O.A. Ajiboye et al.an assessment tool in the selection of patients for lung and
heart surgery [28,29].
Physical characteristics of patients in the control
and exercise groups
This study showed no significant differences in age, height,
weight, body mass index, or 6MWD at baseline between
control and exercise groups. The age of the individuals with
HF who participated in this study were comparable with
other studies done in Nigeria [30,31]. This result also sup-
ported the finding of Kengne et al [32], who reported that
HF in Africa occurs mostly in the 5the6th decade of life.
Thirty-three (55%) of the patients that participated in this
study were females; this finding is consistent with the result
of Mbakwem et al [31]. They reported that 52.1% of their
study population was female.
Effects of exercise training on blood pressure
In this study, exercise training brought about a significant
reduction in resting systolic blood pressure compared with
the control group. This finding is in agreement with the
result of Whelton et al [33], who reported that among three
ethnic groups, black participants had significantly greater
reductions in resting systolic blood pressure and Asian
participants had significantly greater reductions in diastolic
blood pressure compared with white participants. This
result also supported the Kelley [34] study that reported a
small but significant reduction of blood pressure after ex-
ercise intervention.
Effects of exercise training on functional walking
capacity
This study showed a significant increase in 6MWD and esti-
mated peak oxygen uptake in the exercise group after 12
weeks of training. No significant increase was observed in
the measure of functional walking capacity in the control
group. This finding shows that exercise training had a sig-
nificant effect in improving walking capacity of patients in
the exercise group. Similar results were observed by other
researchers [35e37]. The improvement observed in the
walking capacity and increase in the estimated peak oxygen
consumption as assessed by DASI could be attributed to
partial reversal of physical de-conditioning which is an
invariable concomitant of this condition. Deconditioning
may directly or synergistically (with cardiac dysfunction)
worsen many of the adverse organ systemic changes that
occur in HF. Mechanisms behind improved peak oxygen
uptake and improvement in the 6MWD as observed in this
study may be due to reversal of peripheral abnormalities
such as endothelial dysfunction, skeletal muscle wasting
and ventilation inefficiency seen in HF. In chronic HF,
normal mechanisms of vasodilation to exercise are blunted,
rather chronic vasoconstriction are seen. This chronic
vasoconstriction leads to chronic hypoperfusion with
impaired neurovascular response, which becomes more
prominent as the severity of cardiac dysfunction increases
[38]. The improvement observed in the functional capacity
of these patients after the exercise training may beattributed to a reduction in blood pressure and improve-
ment in oxygen saturation after 12 weeks of exercise
training. All of these physiological changes result in an
increased functional capacity and increase in activity level
that directly improved the quality of life of these patients.
Effects of exercise training on activity level
The Veteran’s Specific Activity Questionnaire was adminis-
tered to assess the activity level. This study showed a sig-
nificant improvement in the activity level of patients in the
exercise group, but not the control group. The increase in
activity level noted in this study may further explain the
significant increase in oxygen consumption observed in this
study because oxygen and other nutrients are readily made
available for the muscles for optimal functioning.
Conclusion
This study shows that supervised and structured exercise
training improves function walking capacity and activity
level of individuals with biventricular HF. It is therefore
recommended that patients with chronic systolic biven-
tricular HF who are willing to commence exercise are
advised to consult their health care providers for necessary
medical and physiotherapy assessment for exercise pre-
scription before they enrol for exercise training. Eligible
patients must be subjected to a structured and supervised
training within a hospital setting. Exercise training should
be incorporated as part of the standard treatment of pa-
tients with chronic HF especially individuals with biven-
tricular HF in Nigeria. For easy accessibility, cardiac
rehabilitation centres should be domiciled in all the
teaching and specialist hospitals in all the six geopolitical
zones in Nigeria where exercise training will form core
therapeutic intervention for these patients. Further
research is needed to evaluate the effects of exercise
training in the management of individuals with preserved
ejection fraction (i.e., diastolic HF), the safety and efficacy
of exercise training in acute HF and the effects of exercise
training in children with HF.
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